Source: FDA, published letter. FDA published this warning letter; View Letter opens FDA's copy. To check it, open FDA's record for this establishment, listed under FEI 3018892481.
Violations5
Issue DateApr 20, 2026
Product TypeDrugs
StatusOpen
Letter Details
Firm
Respilon Production S.R.O.
Location
Prikop 843/4 Brno 602 00 Jihomoravsky Czechia
FEI Number
3018892481
Country
Czechia
Issue Date
April 20, 2026
Issuing Office
Center for Drug Evaluation and Research (CDER)
Product Type
Drugs
Status
Open
Subject
CGMP/OTC/Finished Pharmaceuticals/Adulterated
Respilon Production S.R.O. FDA Warning Letter, April 20, 2026
Talk to a Specialist